Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (отвара нови прозор)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Извор‎: Eur J Haematol 1996;56(5):326-8.

Индекс‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (отвара нови прозор)

On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease. (отвара нови прозор)

el-Hazmi MA, al-Momen A, Kandaswamy S, Huraib S, Harakati M, al-Mohareb F, Warsy AS.

Извор‎: Acta Haematol 1995;94(3):128-34.

Индекс‎: PubMed 7502628

https://www.ncbi.nlm.nih.gov/pubmed/7502628 (отвара нови прозор)

Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. (отвара нови прозор)

Little JA, McGowan VR, Kato GJ, Partovi KS, Feld JJ, Maric I, Martyr S, Taylor JG 6th, Machado RF, Heller T, Castro O, Gladwin MT.

Извор‎: Haematologica 2006;91(8):1076-83.

Индекс‎: PubMed 16885048

https://www.ncbi.nlm.nih.gov/pubmed/16885048 (отвара нови прозор)

Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease. (отвара нови прозор)

Tan TL, Ahmad H, Jhavar R, Patel R, Harrison C, Oteng-Ntim E.

Извор‎: J Obstet Gynaecol 2007;27(1):82-3.

Индекс‎: PubMed 17365469

DOI‎: 10.1080/01443610601062739

https://www.ncbi.nlm.nih.gov/pubmed/17365469 (отвара нови прозор)

The use of barbiturate coma as salvage therapy in a postoperative Jehovah's Witness patient with life-threatening anemia. (отвара нови прозор)

Wang SW, Badami CD, Deitch EA.

Извор‎: Am Surg 2009;75(12):1175-8.

Индекс‎: PubMed 19999907

https://www.ncbi.nlm.nih.gov/pubmed/19999907 (отвара нови прозор)